BWXT to sell medical business to Nordic Capital in deal worth up to $800 million

The company will keep a minority stake and continue providing isotope and radiochemical expertise as it shifts capital toward nuclear national security and commercial nuclear power.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.